Back
Chimera Investment 10K Form
Sell
39
CIM
Chimera Investment
Last Price:
4.10
Seasonality Move:
-3.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | CIM/Chimera Investment Quarterly |
2023-08-03 | 10Q | CIM/Chimera Investment Quarterly |
2023-05-04 | 10Q | CIM/Chimera Investment Quarterly |
2022-11-03 | 10Q | CIM/Chimera Investment Quarterly |
2022-08-04 | 10Q | CIM/Chimera Investment Quarterly |
2022-05-05 | 10Q | CIM/Chimera Investment Quarterly |
Receive CIM News And Ratings
See the #1 stock for the next 7 days that we like better than CIM
CIM Financial Statistics
Sales & Book Value
Annual Sales: | $204.77M |
---|---|
Cash Flow: | $31.33M |
Price / Cash Flow: | 4.53 |
Annual Sales: | $10.60 |
Price / Book: | 0.39 |
Profitability
EPS (TTM): | 0.24000 |
---|---|
Net Income (TTM): | $126.1M |
Gross Margin: | $0 |
Return on Equity: | 4.87% |
Return on Assets: | 0.94% |
Chimera Investment Earnings Forecast
Key Chimera Investment Financial Ratios
- The Gross Profit Margin over the past 6 years for CIM is 0.00%.
- The Selling, General & Administrative Expenses for CIM have been equal to 27.20% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 101.54% of Operating Income.
- The Net Earning history of CIM is 61.58% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 7 years.
Chimera Investment Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Mortgage Real Estate Investment Trusts (REITs) |
Sector: | Financials |
Current Symbol: | CIM |
CUSIP: | 16934Q |
Website: | chimerareit.com |
Debt
Debt-to-Equity Ratio: | 3.95 |
---|---|
Current Ratio: | 1.14 |
Quick Ratio: | 1.14 |
Price-to-Earnings
Trailing P/E Ratio: | 18.09 |
---|---|
Forward P/E Ratio: | 6.76 |
CIM Technical Analysis vs Fundamental Analysis
Sell
39
Chimera Investment (CIM)
is a Sell
Is Chimera Investment a Buy or a Sell?
-
Chimera Investment stock is rated a Sell
The current Chimera Investment [CIM] share price is $4.16. The Score for CIM is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.